Huaxia Ophthalmology Stock Market Information
The stock market of Huaxia Ophthalmology (stock code: 301267) provides real-time market data such as five-level market, transaction details, etc. It also summarizes the basic information, major news, research reports, and industry information of Huaxia Ophthalmology. The analysis of the main fund trends and financial data of Huaxia Ophthalmology provides valuable insights for investment decisions.
1. Recent Decline and New Low
Huaxia Ophthalmology, the second largest private ophthalmology service chain group in China, has experienced continuous decline in stock prices. On December 7th, the stock price of Huaxia Ophthalmology approached the lower limit, hitting a new low since its listing. It closed with an 11.84% decline, reaching a minimum price of 32.00 yuan within the day. On December 8th, the stock price of Huaxia Ophthalmology continued to decline.
2. Chairman Under Custody
On December 7th, Huaxia Ophthalmology announced that the actual controller and chairman, Su Qingcan, was detained by the Shanghai Municipal Supervision Commission for personal reasons. On that day, the stock price of Huaxia Ophthalmology plunged by 11.84%, closing at 34.25 yuan per share, setting a new low in 2022. This news has had a significant impact on the stock price.
3. Detailed Stock Information
The stock information of Huaxia Ophthalmology on December 7th shows that the stock price was 33.02 yuan with a decrease of 1.23 yuan or 3.59%. The highest price during the day was 33.93 yuan, the opening price was 33.00 yuan, and the lowest price was 32.79 yuan. The trading volume was 114,000 shares, with a turnover rate of 3.46%. The turnover was 380 million yuan. The line chart, daily chart, weekly chart, and monthly chart provide comprehensive historical price trends.
4. Impact on Stock Market
The news of the chairman being under custody has triggered a significant drop in the stock price of Huaxia Ophthalmology. The stock plunged by more than 16% during the trading session on December 7th, with a trading volume of nearly 600 million yuan. This event has attracted the attention of investors and may continue to affect the stock market of Huaxia Ophthalmology in the short term.
5. Comprehensive Analysis and Reporting
Credit Website provides real-time market information and comprehensive analysis of Huaxia Ophthalmology. It covers the basic information, major news, and industry information of Huaxia Ophthalmology. Users can also browse financial data, market data, company announcements, and major events of Huaxia Ophthalmology. The platform aims to provide investors with a comprehensive understanding of the company for investment decision-making.
In summary, Huaxia Ophthalmology's stock market has experienced a significant decline due to the news of the chairman being under custody. Investors need to closely monitor the stock price trends and the future development of the company. Comprehensive analysis and real-time market information are essential tools for making informed investment decisions.
